Literature DB >> 31828739

How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study.

Domen Pregeljc1, Diana Teodorescu-Perijoc2, Robert Vianello3, Nejc Umek4, Janez Mavri5.   

Abstract

We studied dopamine levels in three compartments of the dopaminergic synapse, including the presynaptic neuron cytosol, dopamine storage vesicles, and the synaptic gap. By considering three transport pathways (dopamine transporter (DAT), vesicular transporter (VT), and exocytosis), four simulated scenarios were investigated: homeostasis, application of cocaine, methamphetamine, and reserpine. Recent experiments show that upon cocaine administration, the Drosophila melanogaster DAT permeation rate constant is decreased by 55% and we adopted this value for the human DAT. Amphetamine and methamphetamine block DAT and VT, while reserpine blocks VT; however, their decreased permeation rate constants are not available. A system of three differential equations of dopamine levels as a function of time was developed respectively for the synaptic compartments and was solved numerically. Per computational inference, the cytosol dopamine concentration was noted to increase in the case of methamphetamine and reserpine, but was practically unchanged in the case of the cocaine administration. Accordingly, our study suggests that amphetamines and other substances that block VT, but not cocaine or substances that only block DAT, may be etiologically important in the cytosolic dopamine mediation of neurodegeneration in Parkinson disease/Parkinsonism.

Entities:  

Keywords:  Amphetamine; Cocaine; Dopamine; Neurodegeneration; Parkinson disease; Reserpine; Synapse

Year:  2019        PMID: 31828739     DOI: 10.1007/s12640-019-00149-0

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  9 in total

1.  Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain.

Authors:  Giuseppe Di Giovanni; Rahul Bharatiya; Emilie Puginier; Marta Ramos; Salomé De Deurwaerdère; Abdeslam Chagraoui; Philippe De Deurwaerdère
Journal:  Front Pharmacol       Date:  2020-06-30       Impact factor: 5.810

2.  Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration.

Authors:  Vignayanandam Ravindernath Muddapu; V Srinivasa Chakravarthy
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

3.  COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes.

Authors:  Lucija Hok; Hrvoje Rimac; Janez Mavri; Robert Vianello
Journal:  Comput Struct Biotechnol J       Date:  2022-02-24       Impact factor: 7.271

4.  Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.

Authors:  Elisabet Jakova; Mohamed Taha Moutaoufik; Jeremy S Lee; Mohan Babu; Francisco S Cayabyab
Journal:  Transl Neurodegener       Date:  2022-02-10       Impact factor: 8.014

5.  Cyclization step of noradrenaline and adrenaline autoxidation: a quantum chemical study.

Authors:  Nejc Umek
Journal:  RSC Adv       Date:  2020-04-28       Impact factor: 3.361

Review 6.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11

Review 7.  L-DOPA in Parkinson's Disease: Looking at the "False" Neurotransmitters and Their Meaning.

Authors:  Abdeslam Chagraoui; Marie Boulain; Laurent Juvin; Youssef Anouar; Grégory Barrière; Philippe De Deurwaerdère
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

8.  How Monoamine Oxidase A Decomposes Serotonin: An Empirical Valence Bond Simulation of the Reactive Step.

Authors:  Alja Prah; Miha Purg; Jernej Stare; Robert Vianello; Janez Mavri
Journal:  J Phys Chem B       Date:  2020-09-10       Impact factor: 2.991

9.  A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions.

Authors:  Sandeep Sathyanandan Nair; Vignayanandam Ravindernath Muddapu; V Srinivasa Chakravarthy
Journal:  Front Comput Neurosci       Date:  2022-01-03       Impact factor: 2.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.